Bogart Wealth LLC’s Fulgent Genetics FLGT Stock Holding History

Bogart Wealth LLC’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40	Closed	-$904	–	1623
2025 Q3	$904	Hold	40	–	–	﹤0.01%	1308
2025 Q2	$795	Hold	40	–	–	﹤0.01%	1253
2025 Q1	$676	Hold	40	–	–	﹤0.01%	1223
2024 Q4	$739	Hold	40	–	–	﹤0.01%	1238
2024 Q3	$869	Hold	40	–	–	﹤0.01%	1035
2024 Q2	$785	Hold	40	–	–	﹤0.01%	1021
2024 Q1	$868	Hold	40	–	–	﹤0.01%	981
2023 Q4	$1.16K	Sell	40 -30	-43%	-$803	﹤0.01%	949
2023 Q3	$1.87K	Hold	70	–	–	﹤0.01%	888
2023 Q2	$2.59K	Hold	70	–	–	﹤0.01%	849
2023 Q1	$2.19K	Hold	70	–	–	﹤0.01%	894
2022 Q4	$2.08K	Buy	70 +40	+133%	+$1.43K	﹤0.01%	787
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	890
2022 Q2	$2K	Hold	30	–	–	﹤0.01%	766
2022 Q1	$2K	Buy	30 +10	+50%	+$658	﹤0.01%	672
2021 Q4	$2K	Hold	20	–	–	﹤0.01%	647
2021 Q3	$2K	Hold	20	–	–	﹤0.01%	627
2021 Q2	$2K	Buy	+20	New	+$1.6K	﹤0.01%	591

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bogart Wealth LLC's FLGT Position: Q4 2025 in Review

Bogart Wealth LLC sold out of Fulgent Genetics (FLGT) in Q4 2025, closing a stake of 40 shares — an estimated $904 sold.

Bogart Wealth LLC first reported a position in FLGT in Q2 2021 and held it in 18 quarters. The position peaked at $2.59K in Q2 2023. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

Bogart Wealth LLC reported no remaining Fulgent Genetics position as of Q4 2025 after selling out during the quarter.
Bogart Wealth LLC sold 40 Fulgent Genetics shares in Q4 2025, an estimated $904.
Bogart Wealth LLC first reported a position in Fulgent Genetics in Q2 2021 and held it in 18 quarters.
Bogart Wealth LLC's Fulgent Genetics position peaked at $2.59K in Q2 2023.
179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Bogart Wealth LLC's 13F filing for Q4 2025, filed 30 Jan 2026.